Patents by Inventor Fouad Brahimi

Fouad Brahimi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combi-molecules having EGFR and DNA targeting properties
    Patent number: 7879861
    Abstract: A series of new chemical agents that demonstrate anti-tumor activity are described. The new chemical agents combine two major mechanisms of anti-tumor action. In an embodiment, the agents are capable of both inhibiting EGFR and damaging DNA while also, upon degradation, degrading to an inhibitor of EGFR and to an agent capable of damaging DNA. Moreover, a novel series of molecules capable of releasing two moles of EGFR inhibitor and a potent bi-functional alkylating agent are also described.
    Type: Grant
    Filed: June 14, 2005
    Date of Patent: February 1, 2011
    Inventors: Bertrand Jean-Claude, Zakaria Rachid, Fouad Brahimi
  • Novel combi-molecules having EGFR and DNA targeting properties
    Publication number: 20060003970
    Abstract: A series of new chemical agents that demonstrate anti-tumor activity are described. The new chemical agents combine two major mechanisms of anti-tumor action. In an embodiment, the agents are capable of both inhibiting EGFR and damaging DNA while also, upon degradation, degrading to an inhibitor of EGFR and to an agent capable of damaging DNA. Moreover, a novel series of molecules capable of releasing two moles of EGFR inhibitor and a potent bi-functional alkylating agent are also described.
    Type: Application
    Filed: June 14, 2005
    Publication date: January 5, 2006
    Inventors: Bertrand Jean-Claude, Zakaria Rachid, Fouad Brahimi